the Safety, Tolerability, and Pharmacokinetics Study of HEC113995

NCT04623814 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
58
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sunshine Lake Pharma Co., Ltd.